Baird Medical Investment Holdings Limited
BDMDNASDAQHealthcare● Active
$1.28
+$0.02(+1.59%)
Market Cap$52453606
P/E Ratio—
52W High$7.262
52W Low$0.757
Baird Medical Investment Holdings Limited (BDMD) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BDMD · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $22.54M | $37.04M | $31.46M | $35.09M | $27.72M |
| Cost of Revenue | $3.65M | $4.38M | $4.23M | $7.05M | $4.54M |
| Gross Profit | $18.88M | $32.65M | $27.23M | $28.04M | $23.18M |
| Gross Margin %(computed) | 83.79% | 88.16% | 86.56% | 79.90% | 83.61% |
| Operating Expenses | |||||
| R&D Expenses | $20.13M | $6.17M | $4.27M | $3.86M | $1.04M |
| G&A Expenses | $14.12M | $5.90M | $8.55M | $6.96M | $6.65M |
| Total Operating Expenses | $44.42M | $17.34M | $15.37M | $13.03M | $9.76M |
| Operating Income | ($25.54M) | $15.32M | $11.86M | $13.63M | $11.92M |
| Operating Margin %(computed) | -113.31% | 41.35% | 37.71% | 38.85% | 42.99% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.01M | $0.00M |
| Interest Expense | $0.74M | $0.58M | $0.28M | $0.30M | $0.15M |
| Income Before Tax | ($26.37M) | $14.09M | $12.36M | $14.52M | $12.61M |
| Income Tax Expense | $1.17M | $1.49M | $1.70M | $1.75M | $2.42M |
| Net Income | ($27.28M) | $12.45M | $10.55M | $12.57M | $11.68M |
| Net Margin %(computed) | -121.04% | 33.62% | 33.52% | 35.82% | 42.12% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.98 | $0.49 | $0.41 | $0.02 | $-0.02 |
| Wtd Avg Shares | 27.79M | 25.56M | 7.58M | 6.29M | 7.19M |
| EBITDA | ($24.53M) | $16.17M | $12.88M | $16.29M | $14.16M |
| EBITDA Margin %(computed) | -108.86% | 43.66% | 40.93% | 46.43% | 51.08% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Baird Medical Investment Holdings Limited data
About Baird Medical Investment Holdings Limited (BDMD) Income Statement
Baird Medical Investment Holdings Limited (BDMD) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BDMD reported revenue of $0.02B, gross profit of $0.02B (gross margin 83.79%), and net income of ($0.03B) — a net profit margin of -121.04%.
Frequently asked questions
BDMD · 4 questionsBaird Medical Investment Holdings Limited (BDMD) reported revenue of $0.02B for 2025, down 39.2% year-over-year.
BDMD revenueBDMD salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09